Fundamentals

Valuation

Metric	Q4	Q1	Δ in %
EV/EBITDA	-60.64	36.39	92.47
Graham Fair Price	12176.27	82.66	0.67
PEG	-100.00	< 0.005	-1906.48
Price/Book	-7.83	3.27	3.55
Price/Cash Flow	941.51	553.78	53.17
Prices/Earnings	-99.99	13.12	190672.03
Price/Sales	-0.39	4.71	4.73
Price/FCF	941.51	553.78	53.17
Naive Interpretation	member

01 - Valuation · Somewhat Weak

Fundamentals

Profitability

Metric	Q4	Q1	Δ in %
Gross Profit Margin	12.05	0.31	0.28
Operating Margin	117.81	0.14	0.06
ROA	1398754.13	0.03	< 0.005
ROE	< 0.005	0.06	1339485.88
ROIC	-41.73	0.04	-99.91
Naive Interpretation	member

02 - Profitability · Not Interpreted

Fundamentals

Financial Growth

Metric	Q4	Q1	Δ in %
Debt QOQ	< 0.005	0.12	-95.27
Dividends QOQ	0.01	-0.01	13.48
EBIT QOQ	3.63	1.10	-69.75
EPS QOQ	1.00	14499.00	1449614.14
FCF QOQ	0.63	-0.91	44.39
Revenue QOQ	-0.03	-0.04	-12.14
Naive Interpretation	member

03 - Financial Growth · Positive

Fundamentals

Leverage & Liquidity

Metric	Q4	Q1	Δ in %
Assets Turnover	n.A.	n.A.	n.A.
Days Inventory Outstanding (DIO)	80.89	89.49	10.63
Days Sales Outstanding (DSO)	73.95	78.28	5.86
Inventory Turnover	1.11	1.01	-9.61
Debt/Capitalization	0.48	0.44	-9.11
Quick Ratio	1.43	1.51	5.32
Naive Interpretation	member

04 - Leverage & Liquidity · Weak

Fundamentals

Per Share Metrics

Metric	Q4	Q1	Δ in %
Book Value	65.82	69.81	6.07
Cash	9.87	8.38	-15.06
Capex	-1.24	-0.74	40.09
Free Cash Flow	4.39	0.41	-90.61
Revenue	49.35	48.44	-1.86
Naive Interpretation	member

05 - Per Share Metrics · Bad

Fundamentals

Financial Health

Metric	Q4	Q1	Δ in %
Current Ratio	2.47	2.64	6.67
Debt/Assets	n.A.	n.A.	n.A.
Debt/Equity	n.A.	n.A.	n.A.
Net Debt/EBITDA	16.86	7.00	-58.46
Naive Interpretation	Member

06 - Financial Health · Bad

Rating